Therefore, these results support an efficient antitumoral activity of BO‐110 exerted at the whole‐body level, with tumor‐secreted MDK as a biomarker of response (more tightly associated with the melanoma cells than IFN, which can be produced by multiple tumor types). The gene discussed is MDK; the disease is melanoma.